Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in J Cancer Res Clin Oncol Retrieve available abstracts of 103 articles: HTML format

Single Articles

April 2024
1. HAO W, Liu W, Chang R, Yang M, et al
   Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world.
   J Cancer Res Clin Oncol. 2024;150:180.
   PubMed     Abstract available
   
   
   March 2024
2. PENG H, Wu X, Zhang C, Liang Y, et al
   Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies.
   J Cancer Res Clin Oncol. 2024;150:153.
   PubMed     Abstract available
   
   
   
3. LI F, Wen Z
   Identification roles of NFE2L3 in digestive system cancers.
   J Cancer Res Clin Oncol. 2024;150:150.
   PubMed     Abstract available
   
   
   
4. WU W, Luo Z, Fang Y, Yu L, et al
   Preoperative ultrasound-guided dual localization with titanium clips and carbon nanoparticles for predicting the surgical approach and guiding the resection of Siewert type II esophagogastric junction adenocarcinoma.
   J Cancer Res Clin Oncol. 2024;150:145.
   PubMed     Abstract available
   
   
   February 2024
5. ZHAO W, Yao Z, Cao J, Liu Y, et al
   Helicobacter pylori upregulates circPGD and promotes development of gastric cancer.
   J Cancer Res Clin Oncol. 2024;150:104.
   PubMed     Abstract available
   
   
   
6. ZHANG C, Wang C, Mao G, Cheng G, et al
   Radiomics analysis of contrast-enhanced computerized tomography for differentiation of gastric schwannomas from gastric gastrointestinal stromal tumors.
   J Cancer Res Clin Oncol. 2024;150:87.
   PubMed     Abstract available
   
   
   January 2024
7. KRIEG S, Loosen S, Krieg A, Luedde T, et al
   Association between iron deficiency anemia and subsequent stomach and colorectal cancer diagnosis in Germany.
   J Cancer Res Clin Oncol. 2024;150:53.
   PubMed     Abstract available
   
   
   
8. LIN W, Zhu Z, Shang Y
   Gastroenteropancreatic neuroendocrine carcinoma in children and adolescents: a population-based study.
   J Cancer Res Clin Oncol. 2024;150:4.
   PubMed     Abstract available
   
   
   November 2023
9. GUO J, Deng Z, Jin L, Yin S, et al
   Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study.
   J Cancer Res Clin Oncol. 2023 Nov 10. doi: 10.1007/s00432-023-05481.
   PubMed     Abstract available
   
   
   
10. LAI H, Zheng J, Zhou G, Li Y, et al
    Clinical characteristics and prognostic outcomes for adenocarcinoma of esophagogastric junction in early-onset patients: a population-based appraisal.
    J Cancer Res Clin Oncol. 2023;149:14941-14952.
    PubMed     Abstract available
    
    
    October 2023
11. KOHLRUSS M, Chakraborty S, Hapfelmeier A, Jesinghaus M, et al
    Low microsatellite instability: A distinct instability type in gastric cancer?
    J Cancer Res Clin Oncol. 2023 Oct 11. doi: 10.1007/s00432-023-05430.
    PubMed     Abstract available
    
    
    September 2023
12. CHEN S, Zhan S, Ding S, Zhang Q, et al
    B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
    J Cancer Res Clin Oncol. 2023 Sep 16. doi: 10.1007/s00432-023-05408.
    PubMed     Abstract available
    
    
    
13. ZHANG S, Zheng L, Zhang Y, Gao Y, et al
    A web-based prediction model for long-term cancer-specific survival of middle-aged patients with early-stage gastric cancer: a multi-institutional retrospective study.
    J Cancer Res Clin Oncol. 2023 Sep 15. doi: 10.1007/s00432-023-05405.
    PubMed     Abstract available
    
    
    
14. LEI X, Cui ZY, Huang XJ
    Exploration of gastric carcinogenesis from the relationship between bile acids and intestinal metaplasia and intragastric microorganisms (H. pylori and non-H. pylori).
    J Cancer Res Clin Oncol. 2023 Sep 14. doi: 10.1007/s00432-023-05407.
    PubMed     Abstract available
    
    
    
15. LIANG T, Cheng M, Lu L, Liu R, et al
    Competing endogenous RNA network characterization of lymph node metastases in Leuran gastric cancer subtypes.
    J Cancer Res Clin Oncol. 2023 Sep 9. doi: 10.1007/s00432-023-05382.
    PubMed     Abstract available
    
    
    
16. HUANG B, Ding F, Li Y
    A practical recurrence risk model based on Lasso-Cox regression for gastric cancer.
    J Cancer Res Clin Oncol. 2023 Sep 6. doi: 10.1007/s00432-023-05346.
    PubMed     Abstract available
    
    
    
17. SHITARA K, George B, Taieb J, Sundar R, et al
    Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS).
    J Cancer Res Clin Oncol. 2023;149:9361-9374.
    PubMed     Abstract available
    
    
    
18. NIE D, Zheng H, An G, Li J, et al
    Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database.
    J Cancer Res Clin Oncol. 2023;149:8593-8603.
    PubMed     Abstract available
    
    
    
19. WANG S, Chen C, Zhang J, Li J, et al
    Prognostic value of blood lipids on patients treated with oxaliplatin combined with S-1 (SOX) after radical gastrectomy and establishment of prognostic nomogram.
    J Cancer Res Clin Oncol. 2023;149:10293-10305.
    PubMed     Abstract available
    
    
    
20. SHEN Y, Li Y, Wang Z, Xu W, et al
    The prognostic value of FAR and a novel FAR-CA125 score in resectable gastric signet ring cell carcinoma patients.
    J Cancer Res Clin Oncol. 2023;149:9597-9608.
    PubMed     Abstract available
    
    
    August 2023
21. WEI C, Ma Y, Wang F, Chen Y, et al
    Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer.
    J Cancer Res Clin Oncol. 2023 Aug 31. doi: 10.1007/s00432-023-05287.
    PubMed     Abstract available
    
    
    
22. LI J, Yang X, Wang X, Jiang Y, et al
    Predicting the prognosis of operable gastric cancer patients by dynamic changes in platelets before and after surgery: a retrospective cohort study.
    J Cancer Res Clin Oncol. 2023 Aug 29. doi: 10.1007/s00432-023-05334.
    PubMed     Abstract available
    
    
    
23. HUO C, Gu Y, Wang D, Zhang X, et al
    STAT1 suppresses the transcriptional activity of TRIM21 in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Aug 28. doi: 10.1007/s00432-023-05307.
    PubMed     Abstract available
    
    
    
24. CORSO G, Comelli G, Veronesi P, Bianchi B, et al
    Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
    J Cancer Res Clin Oncol. 2023 Aug 28. doi: 10.1007/s00432-023-05318.
    PubMed     Abstract available
    
    
    
25. GUO X, Wang Y, Zha L, Li H, et al
    DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Aug 17. doi: 10.1007/s00432-023-05234.
    PubMed     Abstract available
    
    
    
26. WANG J, Yu X, Shi A, Xie L, et al
    Predictive value of (18)F-FDG PET/CT multi-metabolic parameters and tumor metabolic heterogeneity in the prognosis of gastric cancer.
    J Cancer Res Clin Oncol. 2023 Aug 12. doi: 10.1007/s00432-023-05246.
    PubMed     Abstract available
    
    
    
27. NAPPO F, Fornaro L, Pompella L, Catanese S, et al
    Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
    J Cancer Res Clin Oncol. 2023;149:6601-6611.
    PubMed     Abstract available
    
    
    
28. LORDICK F, Thuss-Patience P, Bitzer M, Maurus D, et al
    Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer.
    J Cancer Res Clin Oncol. 2023;149:5937-5950.
    PubMed     Abstract available
    
    
    
29. PLUM PS, Pamuk A, Barutcu AG, Mallmann C, et al
    Two decades of gastric and gastroesophageal junction cancer surgery.
    J Cancer Res Clin Oncol. 2023;149:7679-7688.
    PubMed     Abstract available
    
    
    
30. ABDALLA TSA, Pieper L, Kist M, Thomaschewski M, et al
    Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group.
    J Cancer Res Clin Oncol. 2023;149:7461-7469.
    PubMed     Abstract available
    
    
    
31. WEN Y, Wang Y, Huang Y, Liu Z, et al
    PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:7139-7153.
    PubMed     Abstract available
    
    
    
32. YANG H, Xiang C, Mou Y, Zhou X, et al
    The investigation of volatile organic compounds in diagnosing (early) esophageal squamous cell carcinoma and gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:7029-7041.
    PubMed     Abstract available
    
    
    July 2023
33. YANG X, Zhu Z, Liang T, Lei X, et al
    Comprehensive analysis of anoikis-related genes in prognosis and immune infiltration of gastric cancer based on bulk and single-cell RNA sequencing data.
    J Cancer Res Clin Oncol. 2023 Jul 21. doi: 10.1007/s00432-023-05157.
    PubMed     Abstract available
    
    
    
34. ZHU XD, Zhang LX, Luo PQ, Zhu H, et al
    Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jul 10. doi: 10.1007/s00432-023-05131.
    PubMed     Abstract available
    
    
    
35. XUE Y, Zhang H, Zheng Z, Liu X, et al
    Predictive performance of radiomics for peritoneal metastasis in patients with gastric cancer: a meta-analysis and radiomics quality assessment.
    J Cancer Res Clin Oncol. 2023 Jul 9. doi: 10.1007/s00432-023-05096.
    PubMed     Abstract available
    
    
    
36. SHEN K, Chen B, Gao W
    Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jul 6. doi: 10.1007/s00432-023-05058.
    PubMed     Abstract available
    
    
    
37. YU P, Huang X, Huang L, Dai G, et al
    Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study.
    J Cancer Res Clin Oncol. 2023 Jul 1. doi: 10.1007/s00432-023-05019.
    PubMed     Abstract available
    
    
    
38. VALCARCEL S, Gallego J, Jimenez-Fonseca P, Diez M, et al
    Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
    J Cancer Res Clin Oncol. 2023;149:4077-4089.
    PubMed     Abstract available
    
    
    
39. LI J, Chen Y, Zhang Y, Peng X, et al
    Clinical value and influencing factors of establishing stomach cancer organoids by endoscopic biopsy.
    J Cancer Res Clin Oncol. 2023;149:3803-3810.
    PubMed     Abstract available
    
    
    
40. HUEMER F, Hecht S, Scharinger B, Schlintl V, et al
    Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
    J Cancer Res Clin Oncol. 2023;149:3051-3064.
    PubMed     Abstract available
    
    
    
41. ALBIN J, Fahrig L, Siemanowski J, Rehkaemper J, et al
    FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract.
    J Cancer Res Clin Oncol. 2023;149:5289-5300.
    PubMed     Abstract available
    
    
    
42. XU RH, Zhao XK, Song X, Lei LL, et al
    Survival influence of gender on 42,345 patients with gastric cardia adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:5205-5217.
    PubMed     Abstract available
    
    
    
43. ROSERY V, Mika S, Schmid KW, Reis H, et al
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
    J Cancer Res Clin Oncol. 2023;149:4315-4325.
    PubMed     Abstract available
    
    
    June 2023
44. GASPAR-FIGUEIREDO S, Allemann P, Borgstein ABJ, Joliat GR, et al
    Impact of positive microscopic resection margins (R1) after gastrectomy in diffuse-type gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jun 21. doi: 10.1007/s00432-023-04981.
    PubMed     Abstract available
    
    
    
45. FENG L, Li G, Li D, Duan G, et al
    Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jun 15. doi: 10.1007/s00432-023-04900.
    PubMed     Abstract available
    
    
    
46. ULASE D, Behrens HM, Kruger S, Heckl SM, et al
    LAG3 in gastric cancer: it's complicated.
    J Cancer Res Clin Oncol. 2023 Jun 14. doi: 10.1007/s00432-023-04954.
    PubMed     Abstract available
    
    
    
47. SHEN H, Dang W, Su R, Zhang Z, et al
    Pretreatment lymphocyte-monocyte ratio (LMR) as a superior predictor of short-term progression outcomes in patients with gastric cancer receiving second- and later-line apatinib regimens.
    J Cancer Res Clin Oncol. 2023 Jun 12. doi: 10.1007/s00432-023-04976.
    PubMed     Abstract available
    
    
    
48. WANG L, Xiao K, Dong Z, Meng T, et al
    A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jun 8. doi: 10.1007/s00432-023-04916.
    PubMed     Abstract available
    
    
    
49. MONITTOLA F, Bianchi M, Nasoni MG, Luchetti F, et al
    Gastric cancer cell types display distinct proteasome/immunoproteasome patterns associated with migration and resistance to proteasome inhibitors.
    J Cancer Res Clin Oncol. 2023 Jun 1. doi: 10.1007/s00432-023-04948.
    PubMed     Abstract available
    
    
    May 2023
50. WANG YK, Lv XX, Wang ZQ, Zhou YM, et al
    The significance of the microlymphangiogenesis, microangiogenesis, and combined detection of programmed cell death-1 protein (PD-1)/ki67 in gastric cancer tissues.
    J Cancer Res Clin Oncol. 2023 May 13. doi: 10.1007/s00432-023-04709.
    PubMed     Abstract available
    
    
    
51. MOHRING C, Timotheou A, Manczak A, Sadeghlar F, et al
    Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?
    J Cancer Res Clin Oncol. 2023;149:1849-1862.
    PubMed     Abstract available
    
    
    April 2023
52. ZHAO X, Zhao R, Feng Y, Qiu Z, et al
    The roles EpCAM plays to enhance the malignancy of gastric cancer.
    J Cancer Res Clin Oncol. 2023 Apr 24. doi: 10.1007/s00432-023-04767.
    PubMed     Abstract available
    
    
    
53. ZHU Q, He P, Zheng C, Chen Z, et al
    Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
    J Cancer Res Clin Oncol. 2023 Apr 20. doi: 10.1007/s00432-023-04732.
    PubMed     Abstract available
    
    
    
54. APOSTOLIDIS L, Lang K, Sisic L, Busch E, et al
    Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment.
    J Cancer Res Clin Oncol. 2023;149:1373-1382.
    PubMed     Abstract available
    
    
    March 2023
55. HILTNER T, Kohlruss M, Herz AL, Lorenzen S, et al
    Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
    J Cancer Res Clin Oncol. 2023 Mar 31. doi: 10.1007/s00432-023-04691.
    PubMed     Abstract available
    
    
    
56. ZHANG YY, Li J, Li F, Xue S, et al
    Palmitic acid combined with gamma-interferon inhibits gastric cancer progression by modulating tumor-associated macrophages' polarization via the TLR4 pathway.
    J Cancer Res Clin Oncol. 2023 Mar 2. doi: 10.1007/s00432-023-04655.
    PubMed     Abstract available
    
    
    
57. DING L, Miao X, Jiang X, Chen L, et al
    Adverse outcomes and health-ecological influencing factors of preoperative frailty among elderly patients with gastric cancer.
    J Cancer Res Clin Oncol. 2023 Mar 2. doi: 10.1007/s00432-023-04651.
    PubMed     Abstract available
    
    
    
58. KLEO K, Jovanovic VM, Arndold A, Lehmann A, et al
    Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.
    J Cancer Res Clin Oncol. 2023;149:1049-1061.
    PubMed     Abstract available
    
    
    February 2023
59. SAKASHITA S, Sakamoto N, Kojima M, Taki T, et al
    Requirement of image standardization for AI-based macroscopic diagnosis for surgical specimens of gastric cancer.
    J Cancer Res Clin Oncol. 2023 Feb 11. doi: 10.1007/s00432-022-04570.
    PubMed     Abstract available
    
    
    January 2023
60. CHEN X, Mao D, Li D, Li W, et al
    Identification and validation of a PD-L1-related signature from mass spectrometry in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jan 2. doi: 10.1007/s00432-022-04529.
    PubMed     Abstract available
    
    
    December 2022
61. TAKANO K, Ashikari K, Tamura S, Misawa N, et al
    Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration.
    J Cancer Res Clin Oncol. 2022 Dec 30. doi: 10.1007/s00432-022-04536.
    PubMed     Abstract available
    
    
    
62. YAO G, Fang Y, Fu Y, Xu J, et al
    Tumor budding as an indicator for lymph node metastasis and prognosis of early gastric cancer.
    J Cancer Res Clin Oncol. 2022 Dec 13. doi: 10.1007/s00432-022-04522.
    PubMed     Abstract available
    
    
    
63. NIE H, Wang H, Zhang M, Ning Y, et al
    Comprehensive analysis of cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and immunotherapy response in gastric cancer.
    J Cancer Res Clin Oncol. 2022 Dec 3. doi: 10.1007/s00432-022-04474.
    PubMed     Abstract available
    
    
    November 2022
64. KONDO R, Sakamoto N, Harada K, Hashimoto H, et al
    Cancer-associated fibroblast-dependent and -independent invasion of gastric cancer cells.
    J Cancer Res Clin Oncol. 2022 Nov 22. doi: 10.1007/s00432-022-04484.
    PubMed     Abstract available
    
    
    
65. LI L, Liu P, He C, Xu C, et al
    miRNA-223-3p regulates ECT2 to promote proliferation, invasion, and metastasis of gastric cancer through the Wnt/beta-catenin signaling pathway.
    J Cancer Res Clin Oncol. 2022 Nov 10. pii: 10.1007/s00432-022-04453.
    PubMed     Abstract available
    
    
    
66. FENG J, Tang X, Song L, Zhou Z, et al
    A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer.
    J Cancer Res Clin Oncol. 2022 Nov 5. pii: 10.1007/s00432-022-04456.
    PubMed     Abstract available
    
    
    
67. TANG B, Li M, Xu Y, Li X, et al
    N(6)-methyladenosine (m(6)A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1.
    J Cancer Res Clin Oncol. 2022 Nov 3. pii: 10.1007/s00432-022-04426.
    PubMed     Abstract available
    
    
    October 2022
68. SJOQUIST KM, Martin A, Pavlakis N, Goldstein D, et al
    Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer.
    J Cancer Res Clin Oncol. 2022 Oct 31. pii: 10.1007/s00432-022-04404.
    PubMed     Abstract available
    
    
    
69. ROCKEN C
    Predictive biomarkers in gastric cancer.
    J Cancer Res Clin Oncol. 2022 Oct 19. pii: 10.1007/s00432-022-04408.
    PubMed     Abstract available
    
    
    
70. KIM DS, Kim HJ, Ahn HS
    Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database.
    J Cancer Res Clin Oncol. 2022;148:2855-2865.
    PubMed     Abstract available
    
    
    September 2022
71. PARK SG, Ji MJ, Ham IH, Shin YH, et al
    Secretome analysis reveals reduced expression of COL4A2 in hypoxic cancer-associated fibroblasts with a tumor-promoting function in gastric cancer.
    J Cancer Res Clin Oncol. 2022 Sep 20. pii: 10.1007/s00432-022-04361.
    PubMed     Abstract available
    
    
    
72. ZHANG Y, Zhao ZX, Gao JP, Huang YK, et al
    Tumor-infiltrating CD226(+)CD8(+) T cells are associated with postoperative prognosis and adjuvant chemotherapeutic benefits in gastric cancer patients.
    J Cancer Res Clin Oncol. 2022 Sep 15. pii: 10.1007/s00432-022-04346.
    PubMed     Abstract available
    
    
    
73. KRIEG S, Roderburg C, Fung S, Luedde T, et al
    Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis.
    J Cancer Res Clin Oncol. 2022;148:2235-2246.
    PubMed     Abstract available
    
    
    August 2022
74. XU C, Xie X, Kang N, Jiang H, et al
    Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study.
    J Cancer Res Clin Oncol. 2022 Aug 30. pii: 10.1007/s00432-022-04302.
    PubMed     Abstract available
    
    
    
75. LIU Y, Da M
    Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-beta and enhances chemoradiotherapy resistance.
    J Cancer Res Clin Oncol. 2022 Aug 28. pii: 10.1007/s00432-022-04320.
    PubMed     Abstract available
    
    
    
76. KOLBE K, Haffner I, Schierle K, Maier D, et al
    Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study.
    J Cancer Res Clin Oncol. 2022 Aug 27. pii: 10.1007/s00432-022-04208.
    PubMed     Abstract available
    
    
    July 2022
77. RUAN C, Meng Y, Song H
    CD36: an emerging therapeutic target for cancer and its molecular mechanisms.
    J Cancer Res Clin Oncol. 2022;148:1551-1558.
    PubMed     Abstract available
    
    
    
78. MARGALIT O, Yu S, Shacham-Shmueli E, Strauss G, et al
    Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2022;148:1703-1708.
    PubMed     Abstract available
    
    
    
79. LIU HY, Wang FH, Liang JM, Xiang YY, et al
    Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
    J Cancer Res Clin Oncol. 2022 Jul 1. pii: 10.1007/s00432-022-04124.
    PubMed     Abstract available
    
    
    June 2022
80. BAFUTTO AAF, Castro OAP, Fukuhara DK, de Freitas WR Jr, et al
    Lymph node distribution in patients with remnant gastric cancer.
    J Cancer Res Clin Oncol. 2022 Jun 21. pii: 10.1007/s00432-022-04104.
    PubMed     Abstract available
    
    
    
81. LIU SJ, Huang PD, Xu JM, Li Q, et al
    Diet and gastric cancer risk: an umbrella review of systematic reviews and meta-analyses of prospective cohort studies.
    J Cancer Res Clin Oncol. 2022 Jun 13. pii: 10.1007/s00432-022-04005.
    PubMed     Abstract available
    
    
    May 2022
82. MYER NM, Shitara K, Chung HC, Lordick F, et al
    Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer.
    J Cancer Res Clin Oncol. 2022 May 13. pii: 10.1007/s00432-021-03902.
    PubMed     Abstract available
    
    
    
83. TOYA Y, Shimada T, Hamada K, Watanabe K, et al
    Prediction model of 3-year survival after endoscopic submucosal dissection for early gastric cancer in elderly patients aged >/= 85 years: EGC-2 model.
    J Cancer Res Clin Oncol. 2022 May 11. pii: 10.1007/s00432-022-04024.
    PubMed     Abstract available
    
    
    April 2022
84. SHIMOZAKI K, Shinozaki E, Yamamoto N, Imamura Y, et al
    KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
    J Cancer Res Clin Oncol. 2022 Apr 19. pii: 10.1007/s00432-022-03966.
    PubMed     Abstract available
    
    
    
85. LIU YY, Ruan GT, Ge YZ, Li QQ, et al
    Systemic inflammation with sarcopenia predicts survival in patients with gastric cancer.
    J Cancer Res Clin Oncol. 2022 Apr 18. pii: 10.1007/s00432-022-03925.
    PubMed     Abstract available
    
    
    
86. ATTARD TM, Omar U, Glynn EF, Stoecklein N, et al
    Gastric cancer in the pediatric population, a multicenter cross-sectional analysis of presentation and coexisting comorbidities.
    J Cancer Res Clin Oncol. 2022 Apr 18. pii: 10.1007/s00432-022-03972.
    PubMed     Abstract available
    
    
    March 2022
87. WANG X, Che K, Shi T, Liu Q, et al
    Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.
    J Cancer Res Clin Oncol. 2022 Mar 16. pii: 10.1007/s00432-022-03971.
    PubMed     Abstract available
    
    
    
88. MAEKAWA A, Kudo A, Kishino M, Murase Y, et al
    Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy.
    J Cancer Res Clin Oncol. 2022;148:697-706.
    PubMed     Abstract available
    
    
    February 2022
89. STOLZE T, Franke S, Haybaeck J, Moehler M, et al
    Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis.
    J Cancer Res Clin Oncol. 2022 Feb 25. pii: 10.1007/s00432-022-03953.
    PubMed     Abstract available
    
    
    January 2022
90. WONG Y, Meehan MT, Burrows SR, Doolan DL, et al
    Estimating the global burden of Epstein-Barr virus-related cancers.
    J Cancer Res Clin Oncol. 2022;148:31-46.
    PubMed     Abstract available
    
    
    
91. WANG C, Zhao D, Shu X, Wang K, et al
    Protective effects of all-trans retinoic acid against gastric premalignant lesions by repressing exosomal LncHOXA10-pyruvate carboxylase axis.
    J Cancer Res Clin Oncol. 2022;148:121-135.
    PubMed     Abstract available
    
    
    December 2021
92. CHEN Y, Huang Y, Zhu L, Chen M, et al
    Correction to: SOX2 inhibits metastasis in gastric cancer.
    J Cancer Res Clin Oncol. 2021 Dec 22. pii: 10.1007/s00432-021-03863.
    PubMed    
    
    
    September 2021
93. PAN Z, Fu Z, Luo C, Bao Y, et al
    CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer.
    J Cancer Res Clin Oncol. 2021 Sep 18. pii: 10.1007/s00432-021-03775.
    PubMed     Abstract available
    
    
    May 2021
94. XIE J, Pang Y, Li X, Wu X, et al
    The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    J Cancer Res Clin Oncol. 2021 May 18. pii: 10.1007/s00432-021-03654.
    PubMed     Abstract available
    
    
    
95. LIU Z, Shi M, Li X, Song S, et al
    HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2021;147:1315-1324.
    PubMed     Abstract available
    
    
    April 2021
96. ZHANG Y, Wang F, Sun HR, Huang YK, et al
    Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
    J Cancer Res Clin Oncol. 2021 Apr 23. pii: 10.1007/s00432-021-03633.
    PubMed     Abstract available
    
    
    
97. WAN Q, Zhao R, Xia L, Wu Y, et al
    Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies.
    J Cancer Res Clin Oncol. 2021;147:1077-1087.
    PubMed     Abstract available
    
    
    March 2021
98. ZHANG Q, Ni Y, Zhi X, Wang J, et al
    Involvement of APRIL in Helicobacter pylori-related gastric cancer.
    J Cancer Res Clin Oncol. 2021 Mar 18. pii: 10.1007/s00432-021-03574.
    PubMed     Abstract available
    
    
    
99. NA JE, Lee H, Min YW, Min BH, et al
    Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer.
    J Cancer Res Clin Oncol. 2021 Mar 5. pii: 10.1007/s00432-021-03581.
    PubMed     Abstract available
    
    
    February 2021
100. JIANG L, Gong X, Liao W, Lv N, et al
     Molecular targeted treatment and drug delivery system for gastric cancer.
     J Cancer Res Clin Oncol. 2021 Feb 7. pii: 10.1007/s00432-021-03520.
     PubMed     Abstract available
     
     
     
101. OHNUMA H, Sato Y, Onoyama N, Hamaguchi K, et al
     Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
     J Cancer Res Clin Oncol. 2021 Feb 3. pii: 10.1007/s00432-021-03516.
     PubMed     Abstract available
     
     
     January 2021
102. FAN Y, Liu M, Li S, Yu J, et al
     Surgical and oncological efficacy of laparoscopic-assisted total gastrectomy versus open total gastrectomy for gastric cancer by propensity score matching: a retrospective comparative study.
     J Cancer Res Clin Oncol. 2021 Jan 7. pii: 10.1007/s00432-020-03503.
     PubMed     Abstract available
     
     
     
103. SUN Y, He J, Shi DB, Zhang H, et al
     Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma.
     J Cancer Res Clin Oncol. 2021;147:105-115.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.